Overview

Shivering Prevention During Cesarean Section by Intrathecal Injection of Magnesium Sulfate

Status:
Completed
Trial end date:
2016-12-01
Target enrollment:
Participant gender:
Summary
Shivering is a common post-anesthetic complication occurring in up to 65% of patients undergoing spinal or epidural anesthesia. Shivering may interfere with electrocardiogram, blood pressure and oxygen saturation monitoring. In addition, shivering increases oxygen consumption, carbon dioxide production and metabolic rate by up to 400%. Thus, it may result in problems in patients with low cardiac and pulmonary reserves. Preventing shivering could therefore result in better postoperative outcomes or reduce the incidence of post-surgical complications.
Phase:
Phase 2/Phase 3
Details
Lead Sponsor:
Assiut University
Treatments:
Bupivacaine
Magnesium Sulfate